Ro vs Skinny.Rx

Choose Ro if: You need multiple health services beyond just weight loss (ED treatment, hair loss, dermatology, women's health), want medication flexibility including branded Wegovy options when available, require coordinated care for metabolically-linked conditions, value the 7+ year track record and $1B+ valuation, need a dependable supply for long-term treatment, have multiple health goals requiring integrated platform, or prioritize clinical support and service quality over cost minimization.

Choose Skinny.rx if: You need only basic compounded semaglutide without additional health services, want the absolute lowest GLP-1 pricing available, have no other health needs requiring coordination, can manage independently with minimal clinical support, don't need medication flexibility or branded options, accept significant uncertainty and business failure risk from new market entrant (<2 years), have straightforward weight loss goals without complications, and prioritize maximum cost savings ($1,152-3,312/year) over dependability and multi-category access.

Bottom line: Ro and Skinny.rx represent different value propositions - established multi-category healthcare platform versus ultra-budget single-category startup. Ro charges $100-300/month premium for certainty, medication flexibility, multi-category coordination, and a proven 7+ year run. Skinny.rx offers substantial cost savings but eliminates all multi-category benefits, medication options, and carries significant risk. For patients needing only isolated weight loss treatment and willing to accept business uncertainty, Skinny.rx provides basic access at lowest cost. For those with multiple health needs, those valuing longevity, or those wanting service quality, Ro delivers superior value through multi-category coordination despite higher pricing.